Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,404,096 14.040% | -218,767 (-2.06%) | Filing History |
| 2024-02-02 12:08 pm Purchase | 2023-12-29 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,629,103 7.600% | 440,737 (+8.49%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 6,496,593 8.800% | 1,210,419 (+22.90%) | Filing History |
| 2024-01-24 08:13 am Purchase | 2024-01-24 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 6,701,489 8.400% | 744,931 (+12.51%) | Filing History |
| 2024-01-23 09:38 am Sale | 2023-12-31 | 13G | Avidity Biosciences, Inc. RNA | STATE STREET CORP STT | 3,438,328 4.640% | -131,799 (-3.69%) | Filing History |
| 2023-12-04 4:13 pm Purchase | 2023-11-27 | 13G | Avidity Biosciences, Inc. RNA | BRISTOL MYERS SQUIBB CO BMY | 5,075,304 6.400% | 5,075,304 (New Position) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 10,622,863 14.999% | 5,697,486 (+115.68%) | Filing History |
| 2023-02-14 1:36 pm Sale | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 0 0.000% | -2,759,505 (Position Closed) | Filing History |
| 2023-02-14 12:38 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 6,707,287 10.100% | 1,627,761 (+32.05%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | The Vanguard Group | 3,470,626 5.220% | 3,470,626 (New Position) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 4,925,377 7.412% | 1,148,853 (+30.42%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 5,286,174 8.000% | 1,988,694 (+60.31%) | Filing History |
| 2023-02-03 2:15 pm Purchase | 2022-12-31 | 13G | Avidity Biosciences, Inc. RNA | STATE STREET CORP STT | 3,570,127 5.370% | 3,570,127 (New Position) | Filing History |
| 2023-02-02 4:15 pm Purchase | 2022-09-01 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 5,956,558 9.000% | 1,961,558 (+49.10%) | Filing History |
| 2023-01-11 11:50 am Purchase | 2022-12-30 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 5,188,366 6.450% | 1,924,216 (+58.95%) | Filing History |
| 2022-12-30 4:30 pm Purchase | 2022-12-20 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 5,454,533 8.210% | 5,454,533 (New Position) | Filing History |
| 2022-12-27 4:15 pm Purchase | 2022-12-14 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,762,115 5.070% | 750,000 (+37.27%) | Filing History |
| 2022-08-18 3:38 pm Purchase | 2022-08-05 | 13G | Avidity Biosciences, Inc. RNA | Cowen Financial Products LLC | 3,264,150 6.560% | 3,264,150 (New Position) | Filing History |
| 2022-08-10 2:56 pm Sale | 2022-07-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,079,526 10.200% | -2,652,320 (-34.30%) | Filing History |
| 2022-02-14 3:06 pm Sale | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,012,115 4.290% | -452,432 (-18.36%) | Filing History |